Pricing
Login
Research AI
Products
Watchlists
Pricing
Login
Home
Charts
Search
Watchlist
Products
Senores Pharmaceuticals Ltd
SENORES
₹
1,090.80
-1.99%
Senores Pharmaceuticals Ltd
SENORES
NSE
BSE
₹
1,090.80
-1.99%
20 Nov 2026
Reports
Ask AI
Pharma Formulations
Senores Pharmaceuticals Ltd
SENORES
NSE
BSE
₹
1,090.80
-1.99%
20 Nov 2026
SOIC
x
StockScans Reports
Ask AI
Pharma Formulations
4 indices
Business Overview: What the company does, in plain English.
Growth Catalysts: The forward growth drivers and triggers.
Guidance Report: Management guidance vs outcomes.
Forensic Report: Accounting quality and red flags.
Deep Dive Report: In-depth business analysis.
Financials
Documents
Shareholdings
Corporate Actions
Segments
Reports
Interviews
Announcements
Financials
Documents
Shareholdings
Corporate Actions
Segments
Reports
Interviews
Announcements
Annual Reports
FY2026
PDF
FY2025
PDF
Quarterly Reports
FY2026
Sep 26
Result
PPT
Transcript
Summary
Jun 26
Result
PPT
Transcript
Summary
Mar 26
Result
PPT
Transcript
Summary
Dec 25
Result
PPT
Transcript
Summary
Sep 25
Result
PPT
Transcript
Summary
Jun 25
Result
PPT
Transcript
Summary
Mar 25
Result
PPT
Transcript
Summary
Dec 24
Result
PPT
Transcript
Summary
Annual Reports
FY2026
FY2025
Quarterly Reports
Submit a missing document
Sep 26
Result
PPT
Transcript
Summary
Jun 26
Result
PPT
Transcript
Summary
Mar 26
Result
PPT
Transcript
Summary
Dec 25
Result
PPT
Transcript
Summary
Sep 25
Result
PPT
Transcript
Summary
Jun 25
Result
PPT
Transcript
Summary
Mar 25
Result
PPT
Transcript
Summary
Dec 24
Result
PPT
Transcript
Summary
Load More
Interviews
8:30
A Good Q2 For Senores Pharma | Revenue Growth To Stay Strong At 25-30% Minimum, Says Company
CNBC-TV18
·
3 weeks ago
7:42
Senores Pharma Slumps Post Q1 Numbers; Mgmt Guides For ₹2,500–3,000 Cr Sterile Injectables Revenue
CNBC-TV18
·
4 months ago
7:54
Senores Pharma Jumps 7% After 53% Revenue Growth; Sees 50–60% PAT Growth In FY27 | CNBC TV18
CNBC-TV18
·
6 months ago
Announcements
Announcements